Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Five molecular elements identified as potential future targets for hair loss therapy.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Genomic approach finds new possible treatments for hair loss.

The gene Ascl4 is not necessary for the development of hair, teeth, or mammary glands.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

Nanoparticles around 600-700 nm can effectively enter and stay in hair follicles for days, which may help in delivering drugs to specific cells.

Chemokine signaling is important for hair development.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

New treatments for hair loss may target specific pathways and generate new hair follicles.

Topical treatments can deliver active molecules to skin stem cells, potentially helping treat skin and hair disorders, including skin cancers and hair loss.

Targeting hair follicles can effectively promote hair growth and treat hair disorders.

Google should ban ads targeting cancer patients with sensitive health-related keywords to protect them from misleading information.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

The document concludes that a deeper understanding of skin aging and photodamage is needed to create better skin treatments.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Prolactin contributes to hair loss by promoting hair follicle shrinkage and cell death.

Targeting dermal adipocytes may help combat skin aging.

Vitamin D3 affects cell differentiation in specific skin areas.

Radiation mainly affects keratinocyte stem cells, not melanocyte stem cells, causing hair to gray.

CNGA3, GLUD1, and SIRT1 are promising targets for treating aging and glioblastoma.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Traditional Chinese Medicine and biomaterials help heal chronic wounds by targeting multiple pathways.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

CD2 might be a new treatment target for patchy alopecia areata.

Minoxidil does not work to inhibit lysyl hydroxylases in newborn mouse lungs.

Exosomes show promise for targeted treatment of HER2-positive breast cancer.